# Netupitant + Palonosetron

## Akynzeo 300/0.5mg

| 藥品代碼       | OAKY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:---------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Chemotherapy-induced nausea and vomiting， Acute and delayed; Prophylaxis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量       | Highly emetogenic chemotherapy (including cisplatin-based regimens): Administer netupitant 300 mg/palonosetron 0.5 mg (1 capsule) orally 1 hour prior to chemotherapy on day 1; coadminister dexamethasone 12 mg orally 30 minutes prior to chemotherapy on day 1， and 8 mg QD through day 2 to day 4. Anthracycline and cyclophosphamide-based regimens and other regimens not highly emetogenic: Administer netupitant 300 mg/palonosetron 0.5 mg (1 capsule) orally 1 hour prior to chemotherapy on day 1; coadminister dexamethasone 12 mg orally 30 minutes before chemotherapy on day 1. |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 禁忌           | Specific contraindications have not been determined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 副作用         | Common Dermatologic: Erythema (3% ) Gastrointestinal: Constipation (3% )， Indigestion (4% ) Musculoskeletal: Asthenia (8% ) Neurologic: Headache (9% ) Other: Fatigue (4% to 7% ) Serious Other: Serotonin syndrome                                                                                                                                                                                                                                                                                                                                                                            |
| 孕期用藥建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

